RIC-3 enhances functional expression of multiple nicotinic acetylcholine receptor subtypes in mammalian cells.
Recent studies have shown that RIC-3, originally identified in Caenorhabditis elegans as the protein encoded by the gene resistance to inhibitors of cholinesterase (ric-3), can enhance functional expression of alpha7 nicotinic acetylcholine receptors (nAChRs). In the present study, the influence of C. elegans and human RIC-3 upon multiple homomeric (alpha7, alpha8, and alpha9) and heteromeric (alpha3beta2, alpha3beta4, alpha4beta2, alpha4beta4, and alpha9alpha10) nAChR subtypes has been examined in transfected mammalian cells by radioligand binding and functional characterization. Coexpression of RIC-3 facilitates a dramatic enhancement of the ability of alpha7 (and the closely related alpha8 subunit) to generate functional nAChRs in otherwise nonpermissive mammalian cells. In contrast, coexpression of RIC-3 did not facilitate functional expression of either homomeric alpha9 or heteromeric alpha9alpha10 nAChRs in mammalian cell lines. It is noteworthy that whereas RIC-3 has been reported to cause a marked functional inhibition of heteromeric nAChRs such as alpha3beta4 and alpha4beta2 expressed in Xenopus laevis oocytes, RIC-3 significantly enhances levels of functional expression of these and other (alpha3beta2 and alpha4beta4) heteromeric nAChRs when expressed in mammalian cell lines. In addition, the interaction of multiple nAChR subunits (alpha3, alpha4, alpha7, beta2, and beta4) with RIC-3 has been demonstrated by coimmunoprecipitation from metabolically labeled transfected cells. It is significant that coimmunoprecipitation experiments have provided evidence that RIC-3 associates with unassembled nAChR subunits, a finding that is consistent with previous suggestions that RIC-3 may act by enhancing the maturation (subunit folding and assembly) of nAChRs. We conclude that RIC-3 is an nAChR-associated protein that can enhance functional expression of multiple nAChR subtypes in transfected mammalian cells.
Lansdell
Stuart J
SJ
Department of Pharmacology, University College London, Gower St., London, WC1E 6BT United Kingdom.
Gee
Veronica J
VJ
Harkness
Patricia C
PC
Doward
Anne I
AI
Baker
Elizabeth R
ER
Gibb
Alasdair J
AJ
Millar
Neil S
NS
D000818:Animals; D002460:Cell Line; D006801:Humans; D047468:Immunoprecipitation; D047908:Intracellular Signaling Peptides and Proteins; D011506:Proteins / Q000032:analysis / Q000502:physiology*; D051381:Rats; D011978:Receptors, Nicotinic / Q000032:analysis* / Q000737:chemistry / Q000145:classification / Q000502:physiology; D064569:alpha7 Nicotinic Acetylcholine Receptor
C498540:CHRNA9 protein, human; C579167:Chrna7 protein, human; C579165:Chrna7 protein, rat; D047908:Intracellular Signaling Peptides and Proteins; D011506:Proteins; C496701:RIC3 protein, human; D011978:Receptors, Nicotinic; D064569:alpha7 Nicotinic Acetylcholine Receptor